Association of Number of Incident Cases and Deaths of Cancers with Health Indicators among Iranian Military Community An Ecological Study

Document Type : Original Article


1 Military Epidemiology Research Center, AJA University of Medical Sciences, Tehran, Iran

2 Department of Epidemiology, School of Public Health, Shiraz University of Medical Sciences, Tehran, Iran

3 Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran



Cancers are the second leading cause of death in developing countries. Because of the impact of health indicators on incidence and mortality of many diseases such as cancers and the lack of similar studies in Iran especially among the military community (MC) the current study was aimed to assess the association between the incident cases and deaths of cancers with some health indicators among Iranian MC.
Materials and Methods: 
In the current ecological study, the required data about the cancer patients were earned from the registered cases in the insurance organization of the Iranian MC. Other data were extracted from the statistical center of Iran. Pearson correlation coefficient was used to examine the correlation between the under studied variables. All analyses were done using Stata 14 software. The significance level was set at α = 0.05.
The most incidence and deaths of cancer cases were reported from Tehran, Isfahan, and Khorasan Razavi provinces, respectively. There was a significant correlation between the number of health houses, active health houses, number of hospitals, number of clinics, number of hospital beds, number of literacy people with death, and incidence case of cancers among Iranian MC (P < 0.05).
Health-care centers and the education status of individuals are associated with cancers incidence and mortality. These findings can be very helpful for health planners and policymakers to designing intervention programs to prevent incidence and decrease the burden of these diseases.


1.     Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010;127:2893‑917.
2.     Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015;136:E359‑86.
3.     Keyghobadi N, Rafiemanesh H, Mohammadian‑Hafshejani A, Enayatrad M, Salehiniya H. Epidemiology and trend of cancers in the province of Kerman: Southeast of Iran. Asian Pac J Cancer Prev 2015;16:1409‑13.
4.     Koohi F, Enayatrad M, Salehiniya H. A study of the epidemiology and trends in cancer incidence in Iranian elderly 2003‑2009. Arak Med Univ J 2015;18:57‑66.
5.     Boyle P, Levin B. World Cancer Report 2008: IARC Press, International Agency for Research on Cancer; 2008.
6.     Saadat S, Yousefifard M, Asady H, Moghadas Jafari A, Fayaz M, Hosseini M. The most important causes of death in Iranian population; a retrospective cohort study. Emerg (Tehran) 2015;3:16‑21.
7.     Zhu K, Devesa SS, Wu H, Zahm SH, Jatoi I, Anderson WF, et al. Cancer incidence in the U.S. military population: Comparison with rates from the SEER program. Cancer Epidemiol Biomarkers Prev 2009;18:1740‑5.
8.     GrafN,TournadeMF, deKrakerJ.The role of preoperative chemotherapy in the management of Wilms’ tumor. The SIOP studies. International Society of Pediatric Oncology. Urol Clin North Am 2000;27:443‑54.
9.     Kremer LC, Mulder RL, Oeffinger KC, Bhatia S, Landier W, Levitt G, et al. A worldwide collaboration to harmonize guidelines for the longterm follow-up of childhood and young adult cancer survivors: A report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Pediatr Blood Cancer 2013;60:543‑9.
10.     Go RS, Bartley AC, Crowson CS, Shah ND, Habermann EB, Holton SJ, et al. Association between treatment facility volume and mortality of patients with multiple myeloma. J Clin Oncol 2017;35:598‑604.
11.     Lazarides AL, Kerr DL, Dial BL, Steele JR, Lane WO, Blazer DG 3rd, et al. Does facility volume influence survival in patients with primary malignant bone tumors of the vertebral column? A comparative cohort study. Spine J 2020;20:1106‑13.
12.     Ryan S, Serrell EC, Karabon P, Mills G, Hansen M, Hayn M, et al. The association between mortality and distance to treatment facility inpatients with muscle invasive bladder cancer. J Urol 2018;199:424‑9.
13.     Bhatt VR, Dhakal P, Dahal S, Giri S, Pathak R, Bociek RG, et al. Demographic and other characteristics of nodal non‑Hodgkin’s lymphoma managed in academic versus non‑academic centers. Ther Adv Hematol 2015;6:223‑7.
14.     Giri S, Pathak R, Aryal MR, Karmacharya P, Bhatt VR, Martin MG. Impact of hospital volume on outcomes of patients undergoing chemotherapy for acute myeloid leukemia: A matched cohort study. Blood 2015;125:3359‑60.
15.     Adams SA, Choi SK, Khang L, Campbell DA, Friedman DB, Eberth JM, et al. Decreased cancer mortality‑to‑incidence ratios with increased accessibility of federally qualified health centers. J Community Health 2015;40:633‑41.
16.     Hashim D, Erdmann F, Zeeb H. Editorial: Social inequities in cancer. Front Oncol 2019;9:233.
17.     Lotfi F, Bayati M, Yusefi AR, Ghaderi S, Barati O. Inequality in distribution of health care resources in Iran: Human resources, health centers and hospital beds. Shiraz E-Med J. 2018;19:e63700.
18.     Kada A, Yonemoto N, Yokoyama H, Nonogi H; J‑PULSE III Investigators, Hanada H, et al. Association between accessibility to emergency cardiovascular centers and cardiovascular mortality in Japan. Int J Qual Health Care 2016;28:281‑7.
19.     Whiteman C, Shaver E, Doerr R, Davis SM, Blum F, Davidov D, et al. Trauma patient access: The role of the emergency medical services system in North‑Central West Virginia. W V Med J 2014;110:30‑5.
20.     Bigoni A, Ferreira Antunes JL, Weiderpass E, Kjærheim K. Describing mortality trends for major cancer sites in 133 intermediate regions of Brazil and an ecological study of its causes. BMC Cancer 2019;19:940.
21.     Dornquast C, Willich SN, Reinhold T. Prevalence, mortality, and indicators of health care supply‑association analysis of cardiovascular diseases in Germany. Front Cardiovasc Med 2018;5:158.
22.     Navabi M, Darvishi I. The incidence and mortality of cancer in Eastern Mediterranean Regional Office (EMRO) and its relationship with Human Development Index (HDI): An Ecological Study. Asian Pac J Environ Cancer 2018;1:59‑67.
23.     Herrera‑Serna BY, Lara‑Carrillo E, Toral‑Rizo VH, do Amaral RC, Aguilera‑Eguía RA. Relationship between the human development index and its components with oral cancer in LatinAmerica. J Epidemiol Glob Health 2019;9:223‑32.
24.     Tuvdendorj A, Feenstra T, Tseveen B, Buskens E. Smoking‑attributable burden of lung cancer in Mongolia a data synthesis study on differences between men and women. PLoS One 2020;15:e0229090.
25.     Batty G, Kivimaki M, Gray L, Davey Smith G, Marmot M, Shipley M. Cigarette smoking and site‑specific cancer mortality: Testing uncertain associations using extended follow‑up of the original Whitehall study. Ann Oncol 2008;19:996‑1002.
26.     Bergman BP, Mackay DF, Morrison D, Pell JP. Smoking‑related cancer in military veterans: Retrospective cohort study of 57,000 veterans and 173,000 matched non‑veterans. BMC Cancer 2016;16:311.
27.     Goodarzi E, Beiranvand R, Naemi H, Pordanjani SR, Khazaei Z. Geographical distribution incidence and mortality of breast cancer and its relationship with the human development index (HDI): An ecology study in 2018. World Cancer Res J 2020;7:12.
28.     Soheylizad M, Khazaei S, Rezaeian S. Relation between lung cancer incidence and mortality rates with human development index and its components: A global ecological study. Iran J Cancer Prev 2016;9:5.
29.     Frye TP, Sadowski DJ, Zahnd WE, Jenkins WD, Dynda DI, Mueller GS, et al. Impact of county rurality and urologist density on urological cancer mortality in Illinois. J Urol 2015;193:1608‑13.
30.     Basu S, Berkowitz SA, Phillips RL, Bitton A, Landon BE, Phillips RS. Association of primary care physician supply with population mortality in the United States, 2005‑2015. JAMA Intern Med 2019;179:506‑14.
31.     Nakamura T, Okayama M, Sekine S, Kajii E. Increase in the number of physicians and mortality/life expectancy in Japan. Jichi Med Univ J 2012;35:19‑24.